In today’s highly competitive pharmaceutical landscape, efficiency, visibility, and compliance define success. As the scale of clinical research continues to grow, organizations are shifting from fragmented systems to unified, intelligent platforms....

In the fast-evolving world of clinical research, AI in clinical operations has become a game changer. Yuva Infocare empowers Sponsors, CROs, and research sites to leverage artificial intelligence for smarter workflows, fewer errors, and faster trial.

ARS IWRS is a web-based system that streamlines patient randomization and drug supply management in clinical trials.

ARS CTMS simplifies clinical trials with cloud-based tools for planning, site management, reporting & compliance. Efficient research, simplified.

FDA has taken initiatives to enrol the sound scientific principles that involve prior identification of the loop poles in the manufacturing and operating procedures that provide hindrance in the development of safe, efficacious and effective product with better therapeutic value.

Bioethics guru Arthur Caplan of NYU gives his outspoken and frank opinion on the industry’s minefield of ethical challenges.
Arthur Caplan, professor of bioethics and founding head of the Division of Medical Ethics...

Technologists, working with microbiologists, have made a significant breakthrough in the hunt for new antimicrobials. By using artificial intelligence, a new candidate antibiotic has been identified. The discovery was made using a machine-learning algorithm. This technology enabled scientists to...

As regulatory and competitive landscapes continue to evolve, pharmaceutical, biopharmaceutical and biotechnology companies are discovering that they need to change their traditional approach to product life cycle management.

Translational medicine is an area of research in life sciences that focuses on bringing together early-stage research and development with downstream clinical outcomes to better understand the effects of drugs and therapies for real-world...

Accenture recently surveyed 250 global pharmaceutical and biotechnology leaders to understand the state of digitalisation in biopharmaceutical R&D.
It was found that some progress is being made, but that there was a greater-than-anticipated gap between..

Frontiers Health returns on Wednesday 8th November, for a three-day meeting of minds in the Italian capital of Rome. On Thursday 9th November, however, the thematic session, ‘Science and biomedical research innovation’ will take place...

As COVID-19 spread across the region, disaster readiness paid off. With pandemic scenarios tested in annual exercises, Jovelle Fernandez, Head of Japan Medical Office at Takeda Pharmaceutical, had a plan to reach for. But no plan can anticipate every eventuality and responding to events with flexibility and imagination also proved important.